Tianjin KingYork and Innovata plc Announce $190 Million Asthma JV

Published: Jan 02, 2013

by Richard Daverman, PhD

January 3, 2013 -- Tianjin KingYork Group Co. and Innovata HK Limited have gotten together to form a JV, which will be located in Tianjin Economic-Technological Development Area (TEDA). The new company, which will be known as Tianjin Kinnovata Pharmaceutical Company Limited, will produce powder inhalation drugs for asthma and COPD. The JV has been funded with 60 million RMB ($9.6 million) initially. Over the longer term, the partners plan to invest 1.2 billion RMB ($190 million) in the project. More details....

Back to news